Drug Addiction Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 606

Drug Addiction Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Drug Addiction Global Clinical Trials Review, H2, 2017” provides an overview of Drug Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Laboratorio Reig Jofre SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Laboratorio Reig Jofre SA (Reig Jofre) is a drug company that develops and manufactures medicinal products and nutritional supplements. The company's product categories include specialized technology products, specialty therapeutic areas, and nutritional supplements and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre develops products in liquid dosage forms, semi-solid forms, and solid oral dosage forms. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. It conducts research in the areas of bioequivalence, clinical pharmacokinetics and bioavailability studies, drug interaction, preclinical pharmacokinetics, preclinical toxicoki......
$250

PSR Group BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company's PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provides CRO services such as regulatory consultancy, clinical consultancy and clinical study execution services. PSR orphan works in partnership with Agility Clinical to provide orphan drug development access to its clients. The company's Pharma Resource offers recruitment and interim staff management services to pharmaceutical and biotechnology companies in the areas of medical affairs, regulatory affairs, pharmacovigilance, quality assurance and clinical operations. PSR is headquartered in Hoof......
$250

Kinnov Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company's pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors are used in the treatment of arterial high blood pressurel; and antagonist of 5HT2 and 5HT1C receptors are used in the treatment of allergy. Kinnova's preclinical research and development addiction include identifying the key receptors of addictions, selecting compounds inhibiting these receptors, developing a therapeutic composition for human and validating the concept on proper animal models. It partners with pharma company to conduct phase III studies for its pipeline product. Kinnov is he......
$250

Phosplatin Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract research organizations, pharmaceutical companies and universities across various countries to study the mechanism of action of its lead drug candidate PT-112 in advanced solid tumors. The company markets its products through its network of distributors across the US. Phosplatin Therapeutics is headquartered in New York, the US. Phosplatin Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and......
$250

Impax Laboratories Inc (IPXL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous system (CNS) disorders and other select specialties. The company also has few product candidates in varying stages of development. Impax developed several controlled-release delivery technologies which can be utilized with a variety of oral dosage forms and drugs. It has manufacturing facilities in Hayward, California; Middlesex, New Jersey; and in Taiwan. The company sells its products directly to wholesalers and large retail drug chains and through unrelated third-party pharmaceutical entitie......
$250

Marathon Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile idiopathic arthritis, neuromyelitis optica, idiopathic inflammatory myopathies, catastrophic pediatric epilepsy and multiple sclerosis. Marathon Pharmaceuticals works in partnership with researchers and patient advocates to develop potential new treatments and also to conduct clinical trials. The company seeks to license or acquire orphan products for the treatment of CNS, neurology and movement disorders. Marathon Pharmaceuticals is headquartered in Northbrook, Illinois, the US. Marathon ......
$250

Elsalys Biotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Elsalys Biotech SAS (Elsalys Biotech) is a biotechnology company that designs and develops therapeutic antibodies in oncology and ophthalmology. The company's pipeline products include monoclonal antibodies designed to fight against cancers, vascular eye, idiopathic pulmonary fibrosis and chronic obstructive pulmonary diseases. Its specialization spans from target sourcing to the pre-industrial production of drug candidates. It works in collaboration with academic and other industry partners to conduct programs, clinical evaluation of antibody candidates and to develop immune-based therapies. The company owns and operates laboratories located in the Illkirch Graffenstaden Science and Technology Park. Elsalys Biotech is headquartered in Lyon, France. Elsalys Biotech SAS - Phar......
$250

MEI Pharma Inc (MEIP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company's drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic syndrome and myelofibrosis. Its also develops ME-344, a mitochondrial inhibitor for the treatment of HER2-negative Breast indication; and ME-401, an oral PI3K delta inhibitor for B-cell malignancies. The company partners with other drug developers to produce Pracinostat in AML and myelodysplastic syndrome indications. MEI is headquartered in San Diego, California, the US. MEI Pharma Inc (MEIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and......
$250

Idexx Laboratories Inc (IDXX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), and practice management systems and services. IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. The company offers its products to veterinary, equine, livestock and poultry, water testing and dairy markets. It operates in the Americas, Europe, the Middl......
$250

FUDAN University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary FUDAN University (FUDAN) is an educational university that offers bachelor, undergraduate, master and doctoral degrees in various disciplines. The university confers bachelor's degrees in multiple academic disciplines. It conducts research in various disciplines such as natural sciences, department planning, engineering and medicine, humanities and social sciences, and others. FUDAN operates through departments of philosophy, economics, law, education, literature, history, science, engineering, medicine, and management. The university hosts hundred research institutes that include national key labs and eight ministerial, provincial key labs and engineering centers. It also includes campus including Zhangjiang Campus and Fenglin Campus. FUDAN is headquartered in Shanghai, China. ......
$250